Viral Hepatitis
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2006; 12(4): 561-567
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.561
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Treatment period and virological response rates to lamivudine treatment of Japanese patients with chronic hepatitis B virus infection.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Virological events in all patients during lamivudine treatment period. FU: Follow-up period.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Relationship between treatment period and HBeAg clearance rate during lamivudine treatment of Japanese patients with chronic HBV infection.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Relationship between time of virological response and virological breakthrough rate during lamivudine treatment of Japanese patients with chronic HBV infection. VR: Virological response.
  • Citation: Furusyo N, Takeoka H, Toyoda K, Murata M, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Nomura H, Nakamuta M, Takahashi K, Shimoda S, Azuma K, Sakai H, Hayashi J, Group TKULDS. Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: A project of Kyushu University Liver Disease Study. World J Gastroenterol 2006; 12(4): 561-567
  • URL: https://www.wjgnet.com/1007-9327/full/v12/i4/561.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v12.i4.561